Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC. Schade AE, Kuzmickas R, Rodriguez CL, Mattioli K, et al. PLoS Biol 2023;21:e3002038.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schade AE, Kuzmickas R, Rodriguez CL, Mattioli K, et al. Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC. PLoS Biol 2023;21:e3002038.
PMID: 37104245